May 07, 2025

Dr. Vinay Prasad Shakes Up FDA Leadership

The FDA has appointed Vinay Prasad as its new vaccine chief, shaking up biotech stocks and signaling potential shifts in drug approvals.

Reuters

May 07, 2025

FDA Approves Low-Dose Chlorthalidone Tablet

The FDA has approved HemiClor, a 12.5-mg chlorthalidone tablet, providing patients with a low-dose option.

Conexiant

May 07, 2025

Electric Pulse Procedure May Improve T2D

A minimally invasive procedure using electrical pulses in the small intestine shows promise in significantly improving type 2 diabetes, with benefits rivaling gastric bypass surgery.

Reuters

May 06, 2025

Anemia Linked to Hidden Heart Strain in RA

A new study found that 1 in 3 rheumatoid arthritis patients with normal heart function on standard tests had hidden heart strain detectable only through advanced imaging, with anemia emerging as the strongest predictor.

Conexiant

May 05, 2025

FDA Monthly Round-up: Key April Updates

April’s FDA approvals feature first-in-class therapies, targeted biologics, expanded indications, and innovative delivery systems across allergy, endocrinology, rheumatology, oncology, infectious diseases, and more.

Conexiant

May 01, 2025

Semaglutide Shows Potential in Liver Disease Trial

Phase 3 trial finds weekly semaglutide 2.4mg significantly improved liver histology in patients with MASH and moderate to advanced fibrosis.

Conexiant

April 30, 2025

Is That IPA PFAS-Free?

“Approximately 18% of U.S. breweries are located within zip codes with detectable Per- and polyfluoroalkyl substances (PFAS) in drinking water."

Conexiant

April 29, 2025

Can Five Proteins Predict Liver Disease?

"Imagine if we could predict risk of metabolic dysfunction-associated steatotic liver disease (MASLD) years before it starts."

Conexiant

April 25, 2025

Cinnamon Oil May Trigger Drug Interactions

Cinnamaldehyde may modestly activate drug-metabolizing receptors, raising potential herb–drug interaction concerns.

Conexiant